SURGERY PARTNERS INC
| Market Cap | $1.71B |
| P/E Ratio | — |
| Forward P/E | 27.92 |
| Dividend Yield | — |
| Beta | 1.94 |
| 52W Range | $12.25 - $24.60 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 12 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Doherty David TChief Financial Officer | Sale | 8,867 | $12.50 | $110.84K | 16 Mar 2026 | 16 Mar 2026 |
| Evans Jason EricChief Executive Officer | Sale | 20,400 | $12.47 | $254.39K | 16 Mar 2026 | 16 Mar 2026 |
| Burkhalter DanielleChief Human Resources Officer | Sale | 3,469 | $12.83 | $44.51K | 13 Mar 2026 | 13 Mar 2026 |
| Brittenham MarissaChief Strategy Officer | Sale | 3,657 | $12.54 | $45.86K | 13 Mar 2026 | 13 Mar 2026 |
| Baldock JenniferChief Admin & Dev Officer | Sale | 5,798 | $13.17 | $76.36K | 12 Mar 2026 | 12 Mar 2026 |
| Webb William TrentonAmerican Group President | Sale | 272 | $13.93 | $3.79K | 06 Mar 2026 | 05 Mar 2026 |
| Burkhalter DanielleChief Human Resources Officer | Sale | 7,736 | $13.60 | $105.21K | 06 Mar 2026 | 05 Mar 2026 |
| Doherty David TChief Financial Officer | Sale | 14,574 | $13.84 | $201.70K | 06 Mar 2026 | 05 Mar 2026 |
| Evans Jason EricChief Executive Officer | Sale | 11,462 | $13.79 | $158.06K | 06 Mar 2026 | 05 Mar 2026 |
| Baldock JenniferChief Admin & Dev Officer | Sale | 10,082 | $13.70 | $138.12K | 06 Mar 2026 | 05 Mar 2026 |
| Brittenham MarissaChief Strategy Officer | Sale | 8,785 | $13.70 | $120.35K | 06 Mar 2026 | 05 Mar 2026 |
| Webb William TrentonAmerican Group President | Sale | 1,794 | $13.86 | $24.86K | 05 Mar 2026 | 05 Mar 2026 |
Frequently Asked Questions
What is SGRY stock price today?
SURGERY PARTNERS INC (SGRY) is currently trading at $13.24. The stock has a 52-week range of $12.25 to $24.60 and a market capitalization of $1.71B.
Is SGRY a good stock to buy in 2026?
SURGERY PARTNERS INC has a P/E ratio of N/A (forward P/E: 27.9), a dividend yield of none, and 1-year performance of -45.0%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling SGRY stock?
There have been 12 insider transactions for SGRY in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has SGRY stock performed over the past year?
SURGERY PARTNERS INC (SGRY) has returned -45.0% over the past 12 months. The stock traded between $12.25 and $24.60 during this period, and is currently at $13.24.
Which hedge funds own SGRY (SURGERY PARTNERS INC)?
0 tracked hedge funds currently hold SGRY in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is SGRY's market cap and valuation?
SURGERY PARTNERS INC (SGRY) has a market capitalization of $1.71B. The trailing P/E ratio is N/A and forward P/E is 27.9. The stock is classified in the Healthcare sector.
What is SGRY's revenue and profitability?
SURGERY PARTNERS INC reported revenue of $3.31B with net income of N/A and a profit margin of N/A. The stock has a beta of 1.94.
What sector is SGRY in and who are its biggest institutional holders?
SURGERY PARTNERS INC (SGRY) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.